Citation Impact
Citing Papers
Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma
2008
Mechanisms of Viral Membrane Fusion and Its Inhibition
2001
Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
2010
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy
2012 StandoutScienceNobel
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
2010 Science
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1
2001
Selective Expansion of HIV-1 Envelope Glycoprotein-Specific B Cell Subsets Recognizing Distinct Structural Elements Following Immunization
2009
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Heparin-Protein Interactions
2002 Standout
Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes
2002
Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA
2003
The Role of the CD4 Receptor versus HIV Coreceptors in Envelope-Mediated Apoptosis in Peripheral Blood Mononuclear Cells
2002
Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein
1999
Nicastrin Functions as a γ-Secretase-Substrate Receptor
2005 StandoutNobel
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination
2009
Scorpion-Toxin Mimics of CD4 in Complex with Human Immunodeficiency Virus gp120
2005
MicroRNAs
2004 Standout
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
Distribution and three-dimensional structure of AIDS virus envelope spikes
2006 Nature
Conformational constraints imposed on a pan-neutralizing HIV-1 antibody epitope result in increased antigenicity but not neutralizing response
2004
HIV-1 Broadly Neutralizing Antibody Extracts Its Epitope from a Kinked gp41 Ectodomain Region on the Viral Membrane
2008
Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate
2005
Combinatorial and computational challenges for biocatalyst design
2001 StandoutNatureNobel
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Chemokines and HIV–1 second receptors
1996
Host factors and the pathogenesis of HIV-induced disease
1996 Nature
Neutralizing Antibodies Have Limited Effects on the Control of Established HIV-1 Infection In Vivo
1999
Large quantity production with extreme convenience of human SDF‐1α and SDF‐1β by a Sendai virus vector
1998 StandoutNobel
Crystal Structure of HIV-1 gp41 Including Both Fusion Peptide and Membrane Proximal External Regions
2010
Structures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates
2000
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
1997
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
2012
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
1998 StandoutNature
HIV-1 envelope determinants for cell tropism and chemokine receptor use
1999
Structure of an unliganded simian immunodeficiency virus gp120 core
2005 Nature
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals
2010
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
SNAREpins: Minimal Machinery for Membrane Fusion
1998 StandoutNobel
Core Structure of gp41 from the HIV Envelope Glycoprotein
1997 Standout
Principles for designing ideal protein structures
2012 StandoutNatureNobel
Human Antibodies from Combinatorial Libraries
1994
Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques
1999
Probability Analysis of Variational Crystallization and Its Application to gp120, The Exterior Envelope Glycoprotein of Type 1 Human Immunodeficiency Virus (HIV-1)
1999
Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies
2007
Partial Enzymatic Deglycosylation Preserves the Structure of Cleaved Recombinant HIV-1 Envelope Glycoprotein Trimers
2012
Antibody neutralization and escape by HIV-1
2003 StandoutNature
A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
2014 StandoutNobel
Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site
2008
Membrane Fusion
2003 StandoutNobel
Super-resolution biomolecular crystallography with low-resolution data
2010 StandoutNatureNobel
Virus entry: molecular mechanisms and biomedical applications
2004
Challenges for structure-based HIV vaccine design
2009
Retrospective Analysis of Viral Load and SIV Antibody Responses in Rhesus Macaques Infected with Pathogenic SIV: Predictive Value for Disease Progression
1999
A Blueprint for HIV Vaccine Discovery
2012
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Human Antibody Fragments Specific for Human Blood Group Antigens from a Phage Display Library
1993 StandoutNobel
Click Chemistry on Azidoproline: High‐Affinity Dual Antagonist for HIV‐1 Envelope Glycoprotein gp120
2005
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform 1 1Edited by M. Yaniv
1997 StandoutNobel
How Do Viruses Enter Cells? The HIV Coreceptors Teach Us a Lesson of Complexity
1997
From catalytic asymmetric synthesis to the transcriptional regulation of genes: In vivo and in vitro evolution of proteins
2001 StandoutNobel
Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
2010 StandoutNobel
Mutations That Destabilize the gp41 Core Are Determinants for Stabilizing the Simian Immunodeficiency Virus-CPmac Envelope Glycoprotein Complex
2002
Revealing the world of RNA interference
2004 StandoutNatureNobel
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
2009
Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity
2006
Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment
2005
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation
2011 StandoutNatureNobel
HIV fusion and its inhibition
2001
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Modelling viral and immune system dynamics
2002
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
1997 StandoutNatureNobel
Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects
2010
Cancer-related inflammation
2008 StandoutNature
Efficient Selection of DARPins with Sub-nanomolar Affinities using SRP Phage Display
2008
Novel Insights into Hepatitis C Virus Replication and Persistence
2004
A role for carbohydrates in immune evasion in AIDS
1998
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
2013
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
1998
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees
2004 StandoutNobel
Partial Purification and Characterization of γ-Secretase from Post-mortem Human Brain
2003
Structural Analysis of the Epitope of the Anti-HIV Antibody 2F5 Sheds Light into Its Mechanism of Neutralization and HIV Fusion
2003
Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models
2008
Manufacturing Immunity to Disease in a Test Tube: The Magic Bullet Realized
2006
The antigenic structure of the HIV gp120 envelope glycoprotein
1998 Nature
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Replication of hepatitis C virus
2007 StandoutNobel
High-Resolution Description of Antibody Heavy-Chain Repertoires in Humans
2011
Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.
1996 StandoutNobel
Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope
2004
Structure of the HIV-1 gp41 Membrane-Proximal Ectodomain Region in a Putative Prefusion Conformation,
2009
The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120
2002
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
2011 StandoutScienceNobel
Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
1994 Science
Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein
1999
Increased Macrophage Infection upon Subcutaneous Inoculation of Rhesus Macaques with Simian Immunodeficiency Virus-Loaded Dendritic Cells or T Cells but Not with Cell-Free Virus
2002 StandoutNobel
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Inhibition of Virus Attachment to CD4+ Target Cells Is a Major Mechanism of T Cell Line–adapted HIV-1 Neutralization
1997
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1
1994
Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables
2009
Coreceptors--Implications for HIV Pathogenesis and Therapy
1997 Science
Ablation of the Complementarity-Determining Region H3 Apex of the Anti-HIV-1 Broadly Neutralizing Antibody 2F5 Abrogates Neutralizing Capacity without Affecting Core Epitope Binding
2010
Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120
2002
A Tyrosine-Rich Region in the N Terminus of CCR5 Is Important for Human Immunodeficiency Virus Type 1 Entry and Mediates an Association between gp120 and CCR5
1998
Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism
1997
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
2005
Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 Infection
2001
Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12
1997
Therapeutic Vaccines for Chronic Infections
2004 Science
Immunization with a Live, Attenuated Simian Immunodeficiency Virus Vaccine Leads to Restriction of Viral Diversity in Rhesus Macaques Not Protected from Pathogenic Challenge
1999
Human Immunodeficiency Virus Type 1 Escape from RNA Interference
2003
Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin
2000 Standout
HIV-1 entry inhibitors: Evading the issue
1999
Oligomeric Modeling and Electrostatic Analysis of the gp120 Envelope Glycoprotein of Human Immunodeficiency Virus
2000
A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo
2003
Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades
2002
CD4-Induced Conformational Changes in the Human Immunodeficiency Virus Type 1 gp120 Glycoprotein: Consequences for Virus Entry and Neutralization
1998
Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals
2008
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
2005 Science
Broadly neutralizing anti-hepatitis B virus antibody reveals a complementarity determining region H3 lid-opening mechanism
2007
Ability of the V3 Loop of Simian Immunodeficiency Virus To Serve as a Target for Antibody-Mediated Neutralization: Correlation of Neutralization Sensitivity, Growth in Macrophages, and Decreased Dependence on CD4
2001
Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors
2007
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
Protein grafting of an HIV-1-inhibiting epitope
2003
Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope
2009
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
2012
Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1
1998
Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin
2011 StandoutScienceNobel
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
1998 StandoutScience
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Spontaneous Mutations in the env Gene of the Human Immunodeficiency Virus Type 1 NDK Isolate Are Associated with a CD4-Independent Entry Phenotype
1998
Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
2009
GP120: Biologic Aspects of Structural Features
2001
Structural insights into key sites of vulnerability on HIV ‐1 Env and influenza HA
2012
Relationships between CD4 Independence, Neutralization Sensitivity, and Exposure of a CD4-Induced Epitope in a Human Immunodeficiency Virus Type 1 Envelope Protein
2001
Determinants of CD4 Independence for a Human Immunodeficiency Virus Type 1 Variant Map outside Regions Required for Coreceptor Specificity
1999
A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies
2008
Cu-Catalyzed Azide−Alkyne Cycloaddition
2008 StandoutNobel
Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry
1998
Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining Region
2009
Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
2016
The Long Third Complementarity-Determining Region of the Heavy Chain Is Important in the Activity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5
2004
Neutralizing Monoclonal Antibodies Block Human Immunodeficiency Virus Type 1 Infection of Dendritic Cells and Transmission to T Cells
1998 StandoutNobel
The Decreased Replicative Capacity of Simian Immunodeficiency Virus SIVmac239ΔnefIs Manifest in Cultures of Immature Dendritic Cells and T Cells
2000 StandoutNobel
Increased Neutralization Sensitivity of CD4-Independent Human Immunodeficiency Virus Variants
2001
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains
1997
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Prospects for the Future
2002 StandoutScienceNobel
Role of HIV membrane in neutralization by two broadly neutralizing antibodies
2009
The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120
2002
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Works of James Μ. Binley being referenced
Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C
2008
Targeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses
2011
Broadly Neutralizing Anti-HIV Antibody 4E10 Recognizes a Helical Conformation of a Highly Conserved Fusion-Associated Motif in gp41
2005
Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site
1995
HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy
1999
The Effect of Commencing Combination Antiretroviral Therapy Soon after Human Immunodeficiency Virus Type 1 Infection on Viral Replication and Antiviral Immune Responses
1999
Molecular Profile of an Antibody Response to HIV-1 as Probed by Combinatorial Libraries
1993
A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120
2007
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
1996 Nature
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1
2009
Human Antibody Responses to HIV Type 1 Glycoprotein 41 Cloned in Phage Display Libraries Suggest Three Major Epitopes Are Recognized and Give Evidence for Conserved Antibody Motifs in Antigen Binding
1996
Analysis of the Interaction of Antibodies with a Conserved, Enzymatically Deglycosylated Core of the HIV Type 1 Envelope Glycoprotein 120
1998
HIV–host interactome revealed directly from infected cells
2016
Passive Infusion of Immune Serum into Simian Immunodeficiency Virus-Infected Rhesus Macaques Undergoing a Rapid Disease Course Has Minimal Effect on Plasma Viremia
2000
The Effect of Highly Active Antiretroviral Therapy on Binding and Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 Infection
2000
Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization
2008
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
1999
Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries
1997
Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.
1995
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120–CD4–CCR5 complexes
2002
Nature of Nonfunctional Envelope Proteins on the Surface of Human Immunodeficiency Virus Type 1
2006
Broad Neutralization of Human Immunodeficiency Virus Type 1 Mediated by Plasma Antibodies against the gp41 Membrane Proximal External Region
2009
Determinants of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Activation by Soluble CD4 and Monoclonal Antibodies
1998
Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1
1997
Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies
2004
Antibody Neutralization-Resistant Primary Isolates of Human Immunodeficiency Virus Type 1
1998
HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral Therapy
1998
Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1
2003
Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
1997
Temporal Analyses of Virus Replication, Immune Responses, and Efficacy in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine
1998
Anti-HIV B Cell Lines as Candidate Vaccine Biosensors
2012
Fine Definition of the Epitope on the gp41 Glycoprotein of Human Immunodeficiency Virus Type 1 for the Neutralizing Monoclonal Antibody 2F5
2001
Oligomeric and Conformational Properties of a Proteolytically Mature, Disulfide-Stabilized Human Immunodeficiency Virus Type 1 gp140 Envelope Glycoprotein
2002
Safety and Immunogenicity of ALVAC vCP1452 and Recombinant gp160 in Newly Human Immunodeficiency Virus Type 1-Infected Patients Treated with Prolonged Highly Active Antiretroviral Therapy
2002
Variable-Loop-Deleted Variants of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Can Be Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits
2000
Enzyme Digests Eliminate Nonfunctional Env from HIV-1 Particle Surfaces, Leaving Native Env Trimers Intact and Viral Infectivity Unaffected
2011
Antibody Responses Elicited in Macaques Immunized with Human Immunodeficiency Virus Type 1 (HIV-1) SF162-Derived gp140 Envelope Immunogens: Comparison with Those Elicited during Homologous Simian/Human Immunodeficiency Virus SHIVSF162P4and Heterologous HIV-1 Infection
2006
Antibody Specificities Associated with Neutralization Breadth in Plasma from Human Immunodeficiency Virus Type 1 Subtype C-Infected Blood Donors
2009
Enhancing the Proteolytic Maturation of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins
2002
Redox-Triggered Infection by Disulfide-Shackled Human Immunodeficiency Virus Type 1 Pseudovirions
2003
Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein
1997
A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure
2000
In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope
1996
Role of Complex Carbohydrates in Human Immunodeficiency Virus Type 1 Infection and Resistance to Antibody Neutralization
2010
An Affinity-Enhanced Neutralizing Antibody against the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 gp41 Recognizes an Epitope between Those of 2F5 and 4E10
2007
Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41
2001
Neutralization Sensitivity of Human Immunodeficiency Virus Type 1 Primary Isolates to Antibodies and CD4-Based Reagents Is Independent of Coreceptor Usage
1998
HIV-1 Virus-Like Particles Bearing Pure Env Trimers Expose Neutralizing Epitopes but Occlude Nonneutralizing Epitopes
2012